James M Markert MD
Brain & Spinal Tumor
Professor of Neurological Surgery, University Alabama
Join to View Full Profile
1717 6th Ave SBirmingham, AL 35233
Phone+1 800-822-8816
Dr. Markert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Chair, Department of Neurosurgery
Education & Training
University of MichiganResidency, Neurological Surgery, 1988 - 1995
Columbia University Vagelos College of Physicians and SurgeonsClass of 1988
Certifications & Licensure
AL State Medical License 1995 - 2026
MS State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification MyHealth@UABMedicine, UAB Health System, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Powerchart and Cerner Healthe, Cerner Corporation, 2012, 2014, 2016-2017
Clinical Trials
- Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas Start of enrollment: 2006 Jul 01
- Dose Escalation/De-escalation Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases(RAD 1002) Start of enrollment: 2010 Oct 01
- A Study of Modified Stem Cells in Stable Ischemic Stroke Start of enrollment: 2011 Jan 01
Publications & Presentations
PubMed
- Comparison of 3 vs 5 Fraction Single Isocenter Radiosurgery for Brain Metastases.Luke A Moradi, Richard A Popple, Roman L Travis, Samuel R Marcrom, Kristen O Riley
Advances in Radiation Oncology. 2026-04-01 - Quantitative dynamic granzyme B PET imaging to characterize novel combination immunotherapy response in preclinical glioblastoma models.Carlos A Gallegos, Yun Lu, Patrick N Song, Rodrigo Queiroz, Ugur Akca
Theranostics. 2026-01-01 - HyperArc Automated Stereotactic Radiosurgery Planning Enables Accurate a Priori Fractionation Scheme Selection via Adherence to HyTEC Toxicity Thresholds.Joel A Pogue, John Fiveash, Rex Cardan, Christopher Willey, Natalie Viscariello
Advances in Radiation Oncology. 2025-11-01
Journal Articles
- Original Article Stereotactic Placement of Intratumoral Catheters for Continuous Infusion Delivery of HSV-1 G207 in Pediatric Malignant Supratentorial Brain TumorsAsim K Bag, G Yancey Gillespie, Gregory K Friedman, Zachary Wright, James M Markert, James M Johnston, ScienceDirect
Authored Content
- Clinical Utility of Serum Procalcitonin Level and Infection in the Neurosurgical Intensive Care UnitJanuary 2018
- Clinical Utility of Serum Procalcitonin Level and Infection in the Neurosurgical Intensive Care UnitJanuary 2018
Press Mentions
Leavenworth Discovers Critical Immune Mechanism in Oncolytic Virus TherapySeptember 12th, 2025- Vickers Returns to UAB as the 10th Annual Bland LecturerFebruary 18th, 2025
- UAB Neurosurgery Launches STEM Initiative in Elementary SchoolsJanuary 10th, 2023
Grant Support
- Utilization of Immuno-PET to detect response and guide novel oHSV-based therapy for gliomaUNIVERSITY OF ALABAMA AT BIRMINGHAM2023–2028
- Lessons From The OR: Using Clinical Biologic Correlates To Inform HSV TrialNational Cancer Institute2009–2011
- CT 2001 A Staged Phase I Study Of The Treatment Of Malignant Glioma With G207,National Center For Research Resources2006–2007
- Genetically Engineered HSV 1 In Malignant GliomaNational Center For Research Resources1999–2002
- Engineered Herpes Simplex Virus For Treatment Of GliomasNational Institute Of Neurological Disorders And Stroke1997–2001
Professional Memberships
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
